Streptonigrin and Lavendamycin Partial Structures. Probes for the Minimum, Potent Pharmacophore of Streptonigrin, Lavendamycin, and Synthetic Quinoline-5,8-diones

Journal of Medicinal Chemistry

Volumn 30, Issue 10, 1987, Pages 1918-1928

  Boger, Dale L ^a   Yasuda, Masami ^a   Mitscher, Lester A ^b   Drake, Steven D ^b   Kitos, Paul A ^b   Thompson, Sandra Collins ^b  

^a PURDUE UNIVERSITY   (United States)

^b UNIVERSITY OF KANSAS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINO 3 (7 AMINO 5,8 DIOXO 2 QUINOLYL)BENZOIC ACID; 6 (7 AMINO 5,8 DIOXO 2 QUINOLYL)PICOLINIC ACID; LAVENDAMYCIN; RUFOCROMOMYCIN; STREPTONIGRIN METHYL ESTER; UNCLASSIFIED DRUG;

ANIMAL CELL; BACTERIUM; DRUG CYTOTOXICITY; DRUG SCREENING; DRUG SYNTHESIS; FUNGUS; HUMAN; HUMAN CELL; STRUCTURE ACTIVITY RELATION; TUMOR CELL;

EID: 0000302152     PISSN: 00222623     EISSN: 15204804     Source Type: Journal    
DOI: 10.1021/jm00393a040     Document Type: Article

References (68)

1. Streptonigrin isolation: Rao, K. V.; Cullen, W. P. Antibiot. Annu. 1959, 950. Identical with bruneomycin (Actinomyces albus var. bruneomycini). Kudrina, E. S.; Olkhovatova, O. L.; Murav'eva, L. I.; Gauze, G. F. Antibiotiki (Moscow) 1966,11, 400. Brazhnikova, M. G.; Ponomarenko, V. I.; Kovsharova, I. N.; Kruglyak, E. B.; Proshlyakova, V. V. Antibiotiki (Moscow) 1968,13, 99. Identical with rufochromomycin (Streptomyces rufochromogenus). Chem. Abstr. 1961, 55, 25158.
2. Streptonigrin isolation: Rao, K. V.; Cullen, W. P. Antibiot. Annu. 1959, 950. Identical with bruneomycin (Actinomyces albus var. bruneomycini). Kudrina, E. S.; Olkhovatova, O. L.; Murav'eva, L. I.; Gauze, G. F. Antibiotiki (Moscow) 1966,11, 400. Brazhnikova, M. G.; Ponomarenko, V. I.; Kovsharova, I. N.; Kruglyak, E. B.; Proshlyakova, V. V. Antibiotiki (Moscow) 1968,13, 99. Identical with rufochromomycin (Streptomyces rufochromogenus). Chem. Abstr. 1961, 55, 25158.
3. Streptonigrin structure identification: Rao, K. V.; Biemann, K.; Woodward, R. B. J. Am. Chem. Soc. 1963, 85, 2532.
4. Streptonigrin single-crystal X-ray structure determination: Chiu, Y.-Y.H.; Lipscomb, W. N. J. Am. Chem. Soc. 1975, 97, 2525.
5. Streptonigrin atropisomers: Dholakia, S.; Gillard, R. D. Tetrahedron 1981, 37, 2929.
6. Streptonigrin total syntheses: Weinreb, S. M.; Basha, F. Z.; Hibino, S.; Khatri, N. A.; Kim, D.; Pye, W. E.; Wu, T.-T. J. Am. Chem. Soc. 1982,104, 536. Kende, A. S.; Lorah, D. P.; Boatman, R. J. J. Am. Chem. Soc. 1981, 103, 1271. Boger, D. L.; Panek, J. S. J. Am. Chem. Soc. 1985,107, 5746; J. Org. Chem. 1983, 48, 621.
7. Gould, S. J.; Weinreb, S. M. Fortschr. Chem. Org. Naturst. 1982, 41, 77.
8. Lown, J. W. Mol. Cell. Biochem. 1983, 55, 17.
9. Lown, J. W. In Bioorganic Chemistry; Van Tamelen, E. E., Ed.; Academic: New York, 1977; pp 95-121.
10. Hajdu, J. Metal Ions in Biological Systems; Marcel Dekker: New York, 1985; Vol. 19, Chapter 3.
11. Bhuyan, B. K. In Antibiotics I. Mechanism of Action; Gottlieb, I. D., Shaw, P. D., Eds.; Springer-Verlag: New York, 1967; pp 173-180.
12. Rao, K. V. Cancer Chemother. Rep., Part 2 1974, 4(3), 11.
13. Driscoll, J. S.; Hazard, G. F. Jr.; Wood, B, Jr.; Boldin, A. Cancer Chemother. Rep., Part 2 1974, 4(2), 1.
14. Wilson, W. L.; Labra, C.; Barrist, E. Antibiot. Chemother. (Washington, D.C.) 1961, 11, 147.
15. Oleson, J. J.; Calderella, L. A.; Mjos, K. J.; Reith, A. R.; Thie, R. S.; Toplin, I. Antibiot. Chemother. (Washington, D.C.) 1961, 11, 158.
16. Teller, N.; Wagshul, S. F.; Woolley, G. W. Antibiot. Chemother. (Washington, D.C.) 1961, 11, 165.
17. Reilly, H. C.; Sugiura, K. Antibiot. Chemother. (Washington, D. C.) 1961, 11, 174.
18. Hackethal, C. A.; Golbey, R. B.; Tan, T. C.; Karnofsky, D. A.; Burchenal, J. H. Antibiot. Chemother. (Washington, D.C.) 1961, 11, 178.
19. Chirigos, A.; Pearson, J. W.; Papas, T. S.; Woods, W. A.; Wood, B., Jr.; Spahn, G. Cancer Chemother. Rep., Part 1 1973, 57, 305.
20. McBride, T. J.; Oleson, J. J.; Woolf, D. Cancer Res. 1966,26A, 727.
21. Kuang, D. T.; Whittington, R. M.; Spenser, H.; Patno, M. E. Cancer (Philadelphia) 1969, 23, 597.
22. Nissen, N. L.; Pajak, T.; Glidewell, O.; Blom, H.; Flaherty, M.; Hayes, D.; McIntyre, R.; Holland, J. F. Cancer Treat. Rep. 1977, 61, 1097. Forcier, R. J.; McIntyre, O. R.; Nissen, N. I.; Pajak, T. F.; Glidewell, O.; Holland, J. F. Med. Pediatr. Oncol. 1978, 4, 351.
23. Banzet, P.; Jacquillat, C.; Civatte, J.; Puissant, A.; Maral, J.; Chanstang, C.; Israel, L.; Belaich, S.; Jourdain, J. C.; Weil, M.; Auclerc, G. Cancer (Philadelphia) 1978, 41, 1240.
24. Gout-Lemerle, M.; Rodary, C.; Sarrazin, D. Arch. Fr. Pediatr. 1976, 33, 527.
25. Lavendamycin isolation and antimicrobial and antitumor testing: Balitz, D. M.; Bush, J. A.; Bradner, W. T.; Doyle, T. W.; O'Herron, F. A.; Nettleton, D. E. J. Antibiot. 1982, 35, 259.
26. Lavendamycin structure determination: Doyle, T. W.; Balitz, D. M.; Grulich, R. E.; Nettleton, D. E.; Gould, S. J.; Tann, C.-h.; Moews, A. E. Tetrahedron Lett. 1981, 22, 4595.
27. Lavendamycin biosynthesis: Erickson, W. R.; Gould, S. J. J. Am. Chem. Soc. 1985, 107, 5831. Erickson, W. R.; Gould, S. J. J. Am. Chem. Soc. 1987, 109, 620.
28. Lavendamycin total syntheses: Kende, A. S.; Ebetino, F. H. Tetrahedron Lett. 1984, 25, 923. Hibino, S.; Okazaki, M.; Ichikawa, M.; Sato, K.; Ishizu, T. Heterocycles 1985, 23, 261. Boger, D. L.; Duff, S. R.; Panek, J. S.; Yasuda, M. J. Org. Chem. 1985, 50, 5790. Rao, A. V. R.; Chavan, S. P.; Sivadasan, L. Tetrahedron 1986, 42, 5065.
29. Bachur, N. R.; Gordon, S. L.; Gee, V. Cancer Res. 1978, 38, 1745. Bachur, N. R.; Gordon, S. L.; Gee, V.; Kon, H. Proc. Natl. Acad. Sci. U.S.A. 1979, 76, 954.
30. Cone, R.; Hasan, S. K.; Lown, J. W.; Morgan, A. R. Can. J. Biochem. 1976, 54, 219. No evidence was found for streptonigrin-DNA interaction in the presence or absence of Cu(II).
31. Lown, J. W.; Sim, S.-K. Can. J. Biochem. 1976, 54, 446.
32. Lown, J. W.; Sim, S; Chen, H.-H. Can. J. Biochem. 1978, 56, 1042.
33. Lown, J. W.; Sim, S.-K. Can. J. Chem. 1976, 54, 2563.
34. Ishizu, K.; Dearman, H.; Huang, T.; White, J. R. Biochim. Biophys. Acta 1968, 165, 283.
35. White, J. R.; Dearman, Proc. Natl. Acad. Sci. U.S.A. 1965, 54, 887.
36. White, H. L.; White, J. R. Mol. Pharmacol. 1968, 4, 549.
37. Kremer, W. B.; Laszlo, J. Handb. Exp. Pharmakol. 1975, 38(2), 633.
38. White, H. L.; White, J. R. Biochim. Biophys. Acta 1966,123, 648.
39. Shaikh, I. A.; Johnson, F.; Grollman, A. P. J. Med. Chem. 1986, 29, 1329.
40. Hajdu, J.; Armstrong, E. C. J. Am. Chem. Soc. 1981,103, 232.
41. Isopropylazastreptonigrin: Kremer, W. B.; Laszlo, J. Cancer Chemother. Rep. 1967, 51, 19. Mizuno, N. S. Biochem. Pharmacol. 1967, 16, 933.
42. Streptonigrin methyl ester: Kremer, W. B.; Laszlo, J. Biochem. Pharmacol. 1966, 15, 1111. See also ref 7-13.
43. Streptonigrin hydrazide, streptonigrin amide(s), streptonigrin methyl ester: Inouye, Y.; Oleada, H.; Roy, S. K.; Miyasaka, T.; Hibino, S.; Tanaka, N.; Nakamura, S. J. Antibiot. 1985, 38, 1429.
44. Streptonigrone: Merit, A. J.; Rickards, R. W.; Wu, J.-P. J. Antibiot. 1985, 38, 516.
45. 6-O-Demethylstreptonigrin: Cohen, M.; Shaw, M. W.; Craig, A. P. Proc. Natl. Acad. Sci. U.S.A. 1963, 50, 16.
46. 10'-O-Demethylstreptonigrin: Isshiki, K.; Sawa, T.; Miura, K.; Li, B.; Naganawa, H.; Mamada, M.; Takeuchi, T.; Umezawa, H. J. Antibiot. 1986, 39, 1013.
47. Streptonigrin AB ring system: Liao, T. K.; Nyberg, W. H.; Cheng, C. C. J. Heterocycl. Chem. 1976, 13, 1063. Angew. Chem., Int. Ed. Engl. 1967, 6, 82.
48. Streptonigrin and lavendamycin AB and ABC ring systems: Boger, D. L.; Yasuda, M. Heterocycles 1986, 24, 1067.
49. Streptonigrin ABCD ring system: Kende, A. S.; Naegely, P. C. Tetrahedron Lett. 1978, 4775.
50. Lavendamycin AB, ABC, and CDE γ-carboline ring systems: Boger, D. L.; Duff, S. R.; Panek, J. S.; Yasuda, M. J. Org. Chem. 1985, 50, 5782. Boger, D. L.; Panek, J. S. Tetrahedron Lett. 1984, 25, 3175.
51. Renault, J.; Giorgi-Renault, S.; Baron, M.; Mailliet, P.; Paoletti, C.; Cros, S.; Viosin, E. J. Med. Chem. 1983, 26, 1715. Renault, J.; Giorgi-Renault, S.; Mailliet, P.; Baron, M.; Paoletti, C.; Cros, S. Eur. J. Med. Chem.—Chim. Ther. 1981, 16, 24; 1981, 16, 545; 1983, 18, 134.
52. Hodnett, E. M.; Wongwiechintana, C.; Dunn, W. J., Ill; Marrs, P. J. Med. Chem. 1983, 26, 570 and references cited therein. Albert, A. Selective Toxicity, 4th ed.; Chapman and Hall: London, England, 1973.
53. Creighton, D. J.; Hajdu, J.; Sigman, D. S. J. Am. Chem. Soc. 1976, 98, 4619.
54. Sigman, D. S. Acc. Chem. Res. 1986, 19, 180.
55. Kumar, C. V.; Barton, J. K.; Turro, N. J. J. Am. Chem. Soc. 1985, 107, 5518.
56. Barton, J. K.; Raphael, A. L. Proc. Natl. Acad. Sci. U.S.A. 1985, 82, 6460.
57. Cheng, C. C.; Van, S. J. Org. React. (N.Y.) 1982, 28, 37.
58. Zimmer, H.; Lankin, D. C.; Horgan, S. W. Chem. Rev. 1971, 71, 229.
59. Hibino, S.; Weinreb, S. M. J. Org. Chem. 1977, 42, 232.
60. Kende, A. S.; Ebetino, F. H. Tetrahedron Lett. 1984, 25, 923. Kende, A. S.; Ebetino, F. H.; Battista, R.; Lorah, D. P.; Lodge, E. Heterocycles 1984, 21, 91.
61. Hibino, S.; Okazaki, M.; Ichikawa, M.; Sato, K.; Ishizu, T. Heterocycles 1985, 23, 261.
62. Crivello, J. V. J. Org. Chem. 1981, 46, 3056.
63. Corey, E. J.; Chaykovsky, M. J. J. Am. Chem. Soc. 1965, 87, 1345. Meyers, A. L; Durandetta, J. L.; Marava, R. J. Org. Chem. 1975, 40, 2025.
64. MacKenzie, A. R.; Moody, C. J.; Rees, C. W. Tetrahedron 1986, 42, 3259.
65. Foley, G. E.; Lazarus, H.; Farber, S.; Uzman, B. G.; Boone, B. A.; McCarthy, R. E. Cancer (Philadelphia) 1965, 18, 522. Foley, G. E.; Lazarus, H. Biochem. Pharmacol. 1967, 16, 659.
66. Donoso, J. A.; Himes, R. H. Cancer Biochem. Biophys. 1984, 7, 133.
67. Boger, D. L.; Mitscher, L. A.; Mullican, M. D.; Drake, S. D.; Kitos, P. A. J. Med. Chem. 1985, 28, 1543.
68. Geran, R. I.; Greenberg, N. H.; MacDonald, M.; Schumacher, A. M.; Abbott, B. J. Cancer Chemother. Rep., Part 3 1972, 3(2), 17-20, 59-61.